Načítá se...
P&T Committees Get New Leeway to Control Part C and Part D Drug Costs: Door Opens to More Step Therapy And Indication-Based Formularies
As the door opens to more step therapy and indication-based formularies, P&T committees must walk a fine line between managing treatment costs and providing access to critical drugs.
Uloženo v:
| Vydáno v: | P T |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MediMedia USA, Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6281152/ https://ncbi.nlm.nih.gov/pubmed/30559581 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|